{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:59:21Z","timestamp":1762102761891,"version":"3.41.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>\n                           <jats:sup>64<\/jats:sup>Cu-DOTA-rituximab PET\/CT was performed on a 62-year-old and a 71-year-old men diagnosed with B-cell non-Hodgkin lymphoma. Compared with <jats:sup>18<\/jats:sup>F-FDG PET\/CT, lesions could be detected more sensitively, and it was confirmed that there was no discernible <jats:sup>64<\/jats:sup>Cu-DOTA-rituximab uptake in the tumor other than lymphoma. <jats:sup>64<\/jats:sup>Cu-DOTA-rituximab PET\/CT could be a powerful tool for the diagnosis and monitoring treatment response of lymphoma because of imaging the CD20 expression.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004378","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T04:00:43Z","timestamp":1663732843000},"page":"e82-e83","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["64Cu-DOTA-Rituximab PET\/CT of B-Cell Non-Hodgkin Lymphoma for Imaging the CD20 Expression"],"prefix":"10.1097","volume":"48","author":[{"given":"Inki","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Korea Cancer Centre Hospital, Korea Institute of Radiological and Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilhan","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyo Chul","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Applied RI, Research Institute of Radiological and Medical Sciences, Korea Institutes of Radiological and Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Jin","family":"Kang","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Moo","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Korea Cancer Centre Hospital, Korea Institute of Radiological and Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,9,21]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1182\/blood-2002-09-2778","article-title":"Utility of FDG-PET scanning in lymphoma by WHO classification","volume":"101","year":"2003","journal-title":"Blood"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/cncr.22807","article-title":"The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification","volume":"110","year":"2007","journal-title":"Cancer"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s11912-021-01127-6","article-title":"Current role of functional imaging in the management of lymphoma","volume":"23","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.ejrad.2016.08.011","article-title":"Proportion of false-positive lesions at interim and end-of-treatment FDG-PET in lymphoma as determined by histology: systematic review and meta-analysis","volume":"85","year":"2016","journal-title":"Eur J Radiol"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"e28310","DOI":"10.1002\/pbc.28310","article-title":"Can FDG-PET replace biopsy for the evaluation of residual tumor in pediatric mature B-cell non-Hodgkin lymphoma?","volume":"67","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11307-011-0537-8","article-title":"Positron emission tomography of 64Cu-DOTA-rituximab in a transgenic mouse model expressing human CD20 for clinical translation to image NHL","volume":"14","year":"2012","journal-title":"Mol Imaging Biol"},{"key":"bib7-20250621","article-title":"Validation of 64Cu-DOTA-rituximab injection preparation under good manufacturing practices: a PET tracer for imaging of B-cell non-Hodgkin lymphoma","volume":"14","year":"2015","journal-title":"Mol Imaging"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s12149-021-01607-6","article-title":"Targeted alpha immunotherapy of CD20-positive B-cell lymphoma model: dosimetry estimate of 225Ac-DOTA-rituximab using 64Cu-DOTA-rituximab","volume":"35","year":"2021","journal-title":"Ann Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004378","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:01:57Z","timestamp":1750536117000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,21]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004378","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2022,9,21]]}}}